Skip to main content

Autoimmune Hepatitis Research Studies

Autoimmune hepatitis (AIH) is a chronic - or long lasting - disease in which the body's immune system attacks the normal components, or cells, of the liver and causes inflammation and liver damage.

Learn about the Autoimmune Hepatitis Research Network

Investigator

Craig Lammert, MD

Assistant Professor of Medicine

Open Research Studies for Autoimmune Hepatitis

GRACE: Autoimmune Hepatitis Database

Enrolling: Yes

Principle Investigator: Craig Lammert, MD

Duration: 1 visit

Patient Population: Autoimmune Hepatitis/Pre- and Post- Transplant/Overlap

Interested in this study? Please contact the coordinator below:
Kelsey Green
greenke@iu.edu
(317) 278-9292

A Randomized, Double-blind, Placebo-controlled, Phase 2a Study to Evaluate the Safety and Efficacy of Zetomipzomib (KZR-616) in Patients with Autoimmune Hepatitis

Enrolling: Yes

Principle Investigator: Craig Lammert, MD

Duration: 4 week screening period, 24 week treatment period, 4 week off-treatment safety follow-up period

Patient Population: AIH who have failed standard-of-care treatment, had an incomplete biochemical response to ≥3 months of standard-of-care treatment, or had a disease flare after standard-of-care treatment. 

Drug(s): Zetomipzomib

Interested in this study? Please contact the coordinator below:
Kelsey Green
greenke@iu.edu
(317) 278-9292

Rituximab

Enrolling: Yes

Principle Investigator: Craig Lammert, MD

Duration: 12 months

Patient Population: Aged 18 or greater with AIH.

Drug(s): Rituximab

Interested in this study? Please contact the coordinator below:
Regina Weber
reginaw@iu.edu
(317) 278-3584